Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-01

FDA Approved: EPIDUO — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

The FDA approved a supplemental application for Epiduo, the acne medication combining adapalene and benzoyl peroxide, submitted by Galderma Laboratories, L.P.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPIDUO (adapalene and benzoyl peroxide)

Snippet

SUPPL AP for EPIDUO (ADAPALENE AND BENZOYL PEROXIDE)